| 1 |
34901014 | Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes. | 2021 |
1 |
| 2 |
27458708 | Immunohistochemical loss of 5-hydroxymethylcytosine expression in acute myeloid leukaemia: relationship to somatic gene mutations affecting epigenetic pathways. | 2016 Dec |
1 |
| 3 |
25482556 | DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. | 2014 Dec 11 |
2 |
| 4 |
22391558 | Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. | 2013 Jan 31 |
1 |
| 5 |
22824796 | Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas. | 2013 Jun 20 |
1 |
| 6 |
23634848 | 5-hydroxymethylcytosine and its potential roles in development and cancer. | 2013 May 1 |
2 |
| 7 |
22675360 | The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells. | 2012 |
1 |
| 8 |
21690245 | TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. | 2011 Oct |
1 |